Hans-Hermann Weil

Title: Innovations of Hans-Hermann Weil

Introduction

Hans-Hermann Weil is a notable inventor based in Gau-Bickelheim, Germany. He has made significant contributions to the field of aerosol formulations, particularly in the pharmaceutical industry. With a total of 5 patents, his work has advanced the development of inhalation aerosols and other pharmaceutical products.

Latest Patents

One of his latest patents involves aerosol suspension formulations utilizing TG 227 ea or TG 134 a as propellants. This invention relates to pressurized gas formulations for dosage aerosols, where a medicament is suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane). These formulations are particularly useful for producing inhalation aerosols. Another significant patent focuses on suspension aerosol formulations of pharmaceutical products, which utilize propellant gases such as TG 227, TG 11, TG 12, TGH 114, propane, butane, pentane, or DME for creating powder aerosols.

Career Highlights

Hans-Hermann Weil has worked with prominent companies in the pharmaceutical sector, including Boehringer Ingelheim KG and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise in aerosol technology and pharmaceutical formulations.

Collaborations

Throughout his career, Hans-Hermann Weil has collaborated with notable colleagues such as Ottfried Daab and Adolf Knecht. These partnerships have contributed to the innovative advancements in aerosol formulations and their applications in medicine.

Conclusion

Hans-Hermann Weil's contributions to aerosol technology and pharmaceutical formulations have made a lasting impact in the industry. His innovative patents and collaborations highlight his dedication to advancing medical science through effective aerosol delivery systems.